Response by Lam and Gerstein to Letter Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial"

被引：0
|
作者：
Lam, Carolyn S. P. [1 ,2 ]
Gerstein, Hertzel C. [3 ,4 ]
机构：
[1] Natl Heart Ctr Singapore, Singapore, Singapore
[2] Duke Natl Univ Singapore, Singapore, Singapore
[3] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada
[4] McMaster Univ, Hamilton, ON, Canada
来源：
CIRCULATION | 2022年 / 146卷 / 02期
关键词：
D O I：
10.1161/CIRCULATIONAHA.122.060526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 50 条
  • [1] Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial
    Lam, Carolyn S. P.
    Ramasundarahettige, Chinthanie
    Branch, Kelley R. H.
    Sattar, Naveed
    Rosenstock, Julio
    Pratley, Richard
    Del Prato, Stefano
    Lopes, Renato D.
    Niemoeller, Elisabeth
    Khurmi, Nardev S.
    Baek, Seungjae
    Gerstein, Hertzel C.
    CIRCULATION, 2022, 145 (08) : 565 - 574
  • [2] Letter by Groothof et al Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial"
    Groothof, Dion
    Post, Adrian
    Bakker, Stephan J. L.
    CIRCULATION, 2022, 146 (02) : E5 - E6
  • [3] Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial (vol 145, pg 565, 2022)
    Lam, Carolyn S. P.
    CIRCULATION, 2023, 147 (23) : E720 - E720
  • [4] Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan
    Das, Bhagwan
    Sheikh, Aisha
    Ahmed, Bilal
    Islam, Najmul
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (05) : 1342 - 1346
  • [5] Sodium-Glucose Cotransporter-2 Inhibitors and Prevention of Adverse Kidney Outcomes in Type 2 Diabetes: A Clinical Multiethnic Asian Cohort
    Feng, Liang
    Liew, Zhong Hong
    Bee, Yong Mong
    Jafar, Tazeen H.
    KIDNEY MEDICINE, 2025, 7 (03)
  • [6] Letter by Grocott Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials"
    Grocott, Hilary P.
    CIRCULATION, 2018, 137 (18) : 1983 - 1983
  • [7] Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
    Ferrannini, Ele
    Baldi, Simona
    Frascerra, Silvia
    Astiarraga, Brenno
    Heise, Tim
    Bizzotto, Roberto
    Mari, Andrea
    Pieber, Thomas R.
    Muscelli, Elza
    DIABETES, 2016, 65 (05) : 1190 - 1195
  • [8] Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials"
    Lytvyn, Yuliya
    Bjornstad, Petter
    Udell, Jacob A.
    Lovshin, Julie A.
    Cherney, David Z. I.
    CIRCULATION, 2018, 137 (18) : 1984 - 1985
  • [9] Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial
    Del Prato, Stefano
    Li, Zhuoru
    Ramasundarahettige, Chinthanie
    Branch, Kelley R. H.
    Lam, Carolyn S. P.
    Lopes, Renato D.
    Pratley, Richard
    Rosenstock, Julio
    Sattar, Naveed
    Gerstein, Hertzel C.
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [10] Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes
    van der Hoek, Sjoukje
    Koomen, Jeroen V. V.
    van Bommel, Erik J. M.
    Mosterd, Charlotte M. M.
    Scholtes, Rosalie A. A.
    Hesp, Anne C. C.
    Stevens, Jasper
    van Raalte, Daniel H. H.
    Heerspink, Hiddo J. L.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
12345